test apc anti human cd142 htf 1 miltenyi (Miltenyi Biotec)
Structured Review
Test Apc Anti Human Cd142 Htf 1 Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htf+1/CD142+Antibody%2C+anti-human/pmc11343408__pone__0309112__s001-0-60-65
Average 94 stars, based on 31 article reviews
Images
Related Articles
Incubation:Article Title: An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy Article Snippet: An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy Jantine E. Bakema, Marijke Stigter-van Walsum, Jeffrey R. Harris, Sonja H. Ganzevles, Anantharaman Muthuswamy, Mischa Houtkamp, Theo S. Plantinga, Elisabeth Bloemena, Ruud H. Brakenhoff, Esther C.W.. Breij, and Rieneke van de Ven Magnetic Cell Separation:Article Title: An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy Article Snippet: An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy Jantine E. Bakema, Marijke Stigter-van Walsum, Jeffrey R. Harris, Sonja H. Ganzevles, Anantharaman Muthuswamy, Mischa Houtkamp, Theo S. Plantinga, Elisabeth Bloemena, Ruud H. Brakenhoff, Esther C.W.. Breij, and Rieneke van de Ven Control:Article Title: An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy Article Snippet: An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy Jantine E. Bakema, Marijke Stigter-van Walsum, Jeffrey R. Harris, Sonja H. Ganzevles, Anantharaman Muthuswamy, Mischa Houtkamp, Theo S. Plantinga, Elisabeth Bloemena, Ruud H. Brakenhoff, Esther C.W.. Breij, and Rieneke van de Ven |
